Cargando…
Acute Heart Failure in a Patient with Occult Barlow’s Disease Receiving Bevacizumab
Bevacizumab is a recombinant humanized monoclonal antibody and a key drug for treatment of various types of cancer. Bevacizumab is associated with the occurrence of heart failure, but its risk factors remain unknown. A 55-year-old woman was diagnosed with cervical cancer, which was completely treate...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539381/ https://www.ncbi.nlm.nih.gov/pubmed/34684038 http://dx.doi.org/10.3390/medicina57100998 |